Open for Registration

SGLT2 Inhibitors in Heart Failure — Systematic Review & Meta-Analysis

A structured SRMA group evaluating cardiovascular and renal outcomes of SGLT2 inhibitors in patients with heart failure, following PRISMA methodology with supervised task allocation.

SpecialtyMedicine
Study TypeSystematic Review & Meta-Analysis
Duration40 days
Current Stageresearch_idea

Project Team

SupervisorAhmed osama
CoordinatorMarem Ali
Authorship is earned by contribution

Participation or enrollment does not guarantee authorship or publication. Authorship depends on documented substantive contribution, participation in review, final approval, and accountability for the work.

Is publication guaranteed?

No. IXPath supports rigorous research preparation, while journal acceptance and publication decisions remain with the journal’s independent editorial and peer-review process.

How is authorship determined?

Authorship is based on documented contribution and applicable authorship criteria, not enrollment alone.